Literature DB >> 11003687

New molecular determinant for inactivation of the human L-type alpha1C Ca2+ channel.

N M Soldatov1, S Zhenochin, B AlBanna, D R Abernethy, M Morad.   

Abstract

Molecular cloning of the human fibroblast Ca2+ channel pore-forming alpha1C subunit revealed (Soldatov, 1992. Proc. Natl. Acad. Sci. USA 89:4628-4632) a naturally occurring mutation g2254 --> a that causes the replacement of the conservative alanine for threonine at the position 752 at the cytoplasmic end of transmembrane segment IIS6. Using stably transfected HEK293 cell lines, we have compared electrophysiological properties of the conventional alpha(1C,77) human recombinant L-type Ca2+ channel with those of its mutated isoform alpha(1C,94) containing the A752T replacement. Comparative quantification of steady-state availability of the current carried by alpha(1C,94) and alpha(1C,77) showed that A752T mutation prevented a large (approximately 25%) fraction of the current carried by Ca2+ or Ba2+ from fully inactivating. This mutation, however, did not appear to alter significantly the Ca2+-dependence and kinetics of decay of the inactivating fraction of the current or its voltage-dependence. The data suggests that Ala752 at the cytoplasmic end of IIS6 might serve as a molecular determinant of the Ca2+ channel inactivation, possibly regulating the voltage-dependence of its availability.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11003687     DOI: 10.1007/s002320001106

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  5 in total

1.  Voltage-gated rearrangements associated with differential beta-subunit modulation of the L-type Ca(2+) channel inactivation.

Authors:  Evgeny Kobrinsky; Klaus J F Kepplinger; Alexander Yu; Jo Beth Harry; Heike Kahr; Christoph Romanin; Darrell R Abernethy; Nikolai M Soldatov
Journal:  Biophys J       Date:  2004-08       Impact factor: 4.033

2.  Modulation of the heart's electrical properties by the anticonvulsant drug retigabine.

Authors:  Lena Rubi; Michael Kovar; Eva Zebedin-Brandl; Xaver Koenig; Manuel Dominguez-Rodriguez; Hannes Todt; Helmut Kubista; Stefan Boehm; Karlheinz Hilber
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-20       Impact factor: 4.219

3.  A genetic screen for dihydropyridine (DHP)-resistant worms reveals new residues required for DHP-blockage of mammalian calcium channels.

Authors:  Trevor C Y Kwok; Kwokyin Hui; Wojciech Kostelecki; Nicole Ricker; Guillermo Selman; Zhong-Ping Feng; Peter John Roy
Journal:  PLoS Genet       Date:  2008-05-09       Impact factor: 5.917

4.  Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: a study to assess the drug's cardiac ion channel profile.

Authors:  Xaver Koenig; Michael Kovar; Lena Rubi; Agnes K Mike; Peter Lukacs; Vaibhavkumar S Gawali; Hannes Todt; Karlheinz Hilber; Walter Sandtner
Journal:  Toxicol Appl Pharmacol       Date:  2013-05-22       Impact factor: 4.219

Review 5.  Molecular Determinants of Cav1.2 Calcium Channel Inactivation.

Authors:  Nikolai M Soldatov
Journal:  ISRN Mol Biol       Date:  2012-10-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.